(Q83915557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Alberto Sobrero

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

515-516

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970727-6

7 January 2021

10.1016/S1470-2045(06)70727-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16750502%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference